Craft

Psychemedics

Stock Price

$2.3

2024-10-29

Market Capitalization

$13.7 M

2024-10-28

Revenue

$19.7 M

FY, 2024

Psychemedics Summary

Company Summary

Overview
Psychemedics Corporation provides testing services for the detection of drug abuse through the analysis of hair samples. The Company's tests provide quantitative information that can indicate the approximate amount of drug ingested, as well as historical data, which can show a pattern of individual drug use over a longer period of time. Psychemedics offers its services to employers for applicant and employee testing, treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use.
Type
Public
Status
Active
Founded
1985
HQ
Acton, MA, US | view all locations
Website
https://www.psychemedics.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Raymond C. Kubacki, Chairman, President and C.E.O.

    • Charles Doucot, Executive Vice President

      • Michael I. Schaffer, Vice President-Laboratory Operations

        • Neil L. Lerner, Vice President - Finance

          LocationsView all

          3 locations detected

          • Acton, MA HQ

            United States

            289 Great Rd #200

          • Culver City, CA

            United States

            5832 Uplander Way

          • İstanbul

            Turkey

            Yukarı Dudullu, 3. Cd. No:25

          Psychemedics Financials

          Summary Financials

          Revenue (FY, 2024)
          $19.7M
          Gross profit (FY, 2024)
          $7.1M
          Net income (FY, 2024)
          ($1.9M)
          Cash (FY, 2024)
          $1.4M
          EBIT (FY, 2024)
          ($1.9M)
          Enterprise value
          $12.3M

          Footer menu